Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 325967

Sort by

Sort Order Select

Journal Articles

Isatuximab: surface strike, deep response in AL amyloidosis

Eli Muchtar, Angela Dispenzieri

Blood (2025) 146 (21): 2495–2496.

https://doi.org/10.1182/blood.2025031062

Published: 2025

Journal Articles

iMMune profiling comes of age

Bruno Paiva, Aintzane Zabaleta

Blood (2025) 146 (21): 2496–2498.

https://doi.org/10.1182/blood.2025030836

Published: 2025

Journal Articles

A pooled primate screen finds that MYD88-CD40 boosts CAR-T

Mark B. Leick

Blood (2025) 146 (21): 2498–2499.

https://doi.org/10.1182/blood.2025030745

Published: 2025

Journal Articles

Big cells, bigger BTK resistance in mantle cell lymphoma

Justin Taylor

Blood (2025) 146 (21): 2500–2501.

https://doi.org/10.1182/blood.2025029937

Published: 2025

Journal Articles

Old problems, new tools: ZR2 in older patients with DLBCL

A. Vera de Jonge, Martine E. D. Chamuleau

Blood (2025) 146 (21): 2501–2502.

https://doi.org/10.1182/blood.2025030855

Published: 2025

Journal Articles

Confirmation by conformation: rescue of mutant p53 in AML

David P. Lane

Blood (2025) 146 (21): 2503–2504.

https://doi.org/10.1182/blood.2025030273

Published: 2025

Journal Articles

One lipid to predict them all

Kevin Rouault-Pierre

Blood (2025) 146 (21): 2504–2505.

https://doi.org/10.1182/blood.2025031007

Published: 2025

Journal Articles

Nanobody treatment of von Willebrand disease

James S. O’Donnell

Blood (2025) 146 (21): 2505–2506.

https://doi.org/10.1182/blood.2025031186

Published: 2025

Journal Articles

NPM1 -mutated acute myeloid leukemia with marked erythroid and megakaryocytic differentiation

Xenia Parisi, Sanam Loghavi

Blood (2025) 146 (21): 2612.

https://doi.org/10.1182/blood.2025030468

Published: 2025

Journal Articles

Neri P, Ren L, Azab AK, et al. Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion. Blood. 2011;117(23):6202-6213.

Blood (2025) 146 (21): 2613.

https://doi.org/10.1182/blood.2025031937

Published: 2025

Journal Articles

Lichtenstein DA, Schischlik F, Shao L, et al. Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells. Blood. 2021;138(24):2469-2484.

Blood (2025) 146 (21): 2614.

https://doi.org/10.1182/blood.2025031938

Published: 2025

Journal Articles

Isatuximab for relapsed AL amyloidosis

Blood (2025) 146 (21): 2615.

https://doi.org/10.1182/blood.2025031732

Published: 2025

Journal Articles

Restoring p53 wild-type conformation in TP53 -Y220C–mutant acute myeloid leukemia

Bing Z. Carter, Po Yee Mak, Edward Ayoub, Xiaogang Wu, Baozhen Ke, Yuki Nishida, Andrew Futreal, Lauren B. Ostermann, Andrea D. Bedoy, Steffen Boettcher, Courtney D. DiNardo, Anna Puzio-Kuter, Masha V. Poyurovsky, Arnold Levine, Michael Andreeff

Blood (2025) 146 (21): 2574–2588.

https://doi.org/10.1182/blood.2025028935

Published: 2025

Includes: Supplemental data

Journal Articles

TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma

Blood (2025) 146 (21): 2544–2560.

https://doi.org/10.1182/blood.2024026919

Published: 2025

Includes: Supplemental data

Journal Articles

Pooled CAR-T screening in pig-tailed macaques identifies designs with enhanced proliferation, trafficking, and persistence

Blood (2025) 146 (21): 2531–2543.

https://doi.org/10.1182/blood.2025028683

Published: 2025

Includes: Supplemental data

Journal Articles

A T-cell–based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy

Wassilis S. C. Bruins, Febe Smits, Carolien Duetz, Kaz Groen, Charlotte L. B. M. Korst, A. Vera de Jonge, Christie P. M. Verkleij, Rosa Rentenaar, Meliha Cosovic, Merve Eken, Inoka Twickler, Paola M. Homan-Weert, Pieter Sonneveld, Philippe Moreau, Jürgen Claesen, Niels W. C. J. van de Donk, Sonja Zweegman, Tuna Mutis

Blood (2025) 146 (21): 2517–2530.

https://doi.org/10.1182/blood.2025028587

Published: 2025

Includes: Supplemental data

Journal Articles

A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma

Peng-Peng Xu, Yue Zhu, Zi-Yang Shi, Li Wang, Shu Cheng, Ying Qian, Yan Zhao, Yang He, Hong-Mei Yi, Bin-shen Ou-yang, Xu-Feng Jiang, Biao Li, Qi Song, Rong-Ji Mu, Wei-Li Zhao

Blood (2025) 146 (21): 2561–2573.

https://doi.org/10.1182/blood.2025028649

Published: 2025

Includes: Supplemental data

Journal Articles

Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia

Cristiana O’Brien, Nirvana Nursimulu, Anit Tyagi, Rachel Culp-Hill, Andrea Arruda, Tracy Murphy, Mark D. Minden, Andrew Kent, Brett Stevens, Daniel A. Pollyea, Kristin Hope, Sushant Kumar, Julie A. Reisz, Angelo D'Alessandro, Courtney L. Jones

Blood (2025) 146 (21): 2589–2596.

https://doi.org/10.1182/blood.2025029132

Published: 2025

Includes: Supplemental data

Journal Articles

A bispecific nanobody for the treatment of von Willebrand disease type 1

Ivan Peyron, Caterina Casari, Geneviève McCluskey, Vincent Licari, Emilie Bocquet, Claire Auditeau, Mélanie Y. Daniel, Stéphanie Roullet, Sophie Susen, Olivier D. Christophe, Peter J. Lenting, Cécile V. Denis

Blood (2025) 146 (21): 2597–2607.

https://doi.org/10.1182/blood.2025029401

Published: 2025

Includes: Supplemental data

Journal Articles

Isatuximab for relapsed and/or refractory AL amyloidosis: results of a prospective phase 2 trial (SWOG S1702)

Terri L. Parker, Adam Rosenthal, Vaishali Sanchorawala, Heather J. Landau, Erica L. Campagnaro, Prashant Kapoor, Natalia Neparidze, Saulius Girnius, Patrick Hagen, Emma C. Scott, Antje Hoering, Brian G. M. Durie, Robert Z. Orlowski

Blood (2025) 146 (21): 2507–2516.

https://doi.org/10.1182/blood.2024027962

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Isatuximab: surface strike, deep response in AL amyloidosis

iMMune profiling comes of age

A pooled primate screen finds that MYD88-CD40 boosts CAR-T

Big cells, bigger BTK resistance in mantle cell lymphoma

Old problems, new tools: ZR2 in older patients with DLBCL

Confirmation by conformation: rescue of mutant p53 in AML

One lipid to predict them all

Nanobody treatment of von Willebrand disease

NPM1 -mutated acute myeloid leukemia with marked erythroid and megakaryocytic differentiation

Neri P, Ren L, Azab AK, et al. Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion. Blood. 2011;117(23):6202-6213.

Lichtenstein DA, Schischlik F, Shao L, et al. Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells. Blood. 2021;138(24):2469-2484.

Isatuximab for relapsed AL amyloidosis

Restoring p53 wild-type conformation in TP53 -Y220C–mutant acute myeloid leukemia

TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma

Pooled CAR-T screening in pig-tailed macaques identifies designs with enhanced proliferation, trafficking, and persistence

A T-cell–based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy

A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma

Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia

A bispecific nanobody for the treatment of von Willebrand disease type 1

Isatuximab for relapsed and/or refractory AL amyloidosis: results of a prospective phase 2 trial (SWOG S1702)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only